PO23-744 PROJECTED PERCENT LDL-C REDUCTION & NCEP-III CHOLESTEROL GOAL ATTAINMENT WITH EZETIMIBE/SIMVASTATIN IN A COHORT OF GUBBIO PATIENTS NOT AT GOAL ON STATIN MONOTHERAPY